These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 21529741
21. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group. Am J Cardiol; 2009 Nov 15; 104(10):1362-9. PubMed ID: 19892051 [Abstract] [Full Text] [Related]
23. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ, SPIRIT IV Investigators. N Engl J Med; 2010 May 06; 362(18):1663-74. PubMed ID: 20445180 [Abstract] [Full Text] [Related]
24. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A. Circulation; 2007 Jun 26; 115(25):3181-8. PubMed ID: 17562952 [Abstract] [Full Text] [Related]
31. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry. Dou KF, Xu B, Yang YJ, Chen JL, Qiao SB, Li JJ, Qin XW, Liu HB, Wu YJ, Chen J, Yao M, You SJ, Yuan JQ, Dai J, Gao RL. Chin Med J (Engl); 2009 Mar 20; 122(6):612-6. PubMed ID: 19323921 [Abstract] [Full Text] [Related]
32. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry. Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A. Int J Cardiol; 2010 Apr 15; 140(2):154-60. PubMed ID: 19056134 [Abstract] [Full Text] [Related]
33. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group. Simonton CA, Brodie B, Cheek B, Krainin F, Metzger C, Hermiller J, Juk S, Duffy P, Humphrey A, Nussbaum M, Laurent S, STENT Group. J Am Coll Cardiol; 2007 Sep 25; 50(13):1214-22. PubMed ID: 17888837 [Abstract] [Full Text] [Related]
35. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry. Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ. J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467 [Abstract] [Full Text] [Related]
38. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). Roy P, Bonello L, de Labriolle A, Okabe T, Pinto Slottow TL, Steinberg DH, Torguson R, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Am J Cardiol; 2008 Aug 01; 102(3):292-7. PubMed ID: 18638589 [Abstract] [Full Text] [Related]